SMN2 and proximal spinal muscular atrophy: Knockdown of SMN-AS1 in fibroblasts by treatment with a chemically modified oligonucleotide increased SMN2 expression sixfold, a potential approach to the degenerative disease spinal muscular atrophy (SMA)23.